Skip to main content
Veterinary Medicines

TERRAMYCIN 75.5% ΚΟΝΙΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ

Authorised
  • Oxytetracycline hydrochloride

Product identification

Medicine name:
TERRAMYCIN 75.5% ΚΟΝΙΣ ΓΙΑ ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ
Active substance:
  • Oxytetracycline hydrochloride
Target species:
  • Turkey
  • Rabbit
  • Mink
  • Chicken
  • Goose
  • Duck
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Oxytetracycline hydrochloride
    76.80
    milligram(s)
    /
    100.00
    gram(s)
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • Oral use
    • Turkey
      • Meat and offal
        10
        day
    • Rabbit
      • Not applicable
        no withdrawal period
    • Mink
      • Not applicable
        no withdrawal period
    • Chicken
      • Meat and offal
        10
        day
      • Egg
        0
        day
    • Goose
      • Meat and offal
        10
        day
      • Egg
        0
        day
    • Duck
      • Meat and offal
        10
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01AA06
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Hellas S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Famar Anonymous Industrial Single Member Company Of Pharmaceuticals And Cosmetics
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 51838-13/07/2012-/16/04/2013/K-0046708
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."